Atomoxetine QT Prolongation: What Patients and Clinicians Should Know
Learn what atomoxetine QT prolongation means, who may be at risk, how to monitor heart safety, and when to seek medical advice.
Methylphenidate vs Lisdexamfetamine in Adults: Benefits, Side Effects, and How to Choose
Compare methylphenidate vs lisdexamfetamine for adults with ADHD, including effectiveness, side effects, duration, FAQs, and key decision factors.
ADHD Medication Initiation Checklist: What to Do Before, During, and After Starting Treatment
Learn what to ask, track, and prepare before starting ADHD medication with this practical initiation checklist, FAQs, and safety tips.
Elvanse Prescribing Guidelines for Adults: Safe ADHD Treatment in the UK
Learn the key Elvanse prescribing guidelines for adults in the UK, including assessment, monitoring, contraindications, titration, shared care and FAQs.
Lisdexamfetamine Contraindications UK: What Clinicians and Patients Need to Know
Learn the main lisdexamfetamine contraindications in the UK, including cardiovascular, psychiatric and medication risks, plus FAQs and safety guidance.
Weiss ADHD Review Tool: A Practical Guide for Adult ADHD Assessment
Discover how the Weiss ADHD review tool supports adult ADHD assessment, symptom review, impairment tracking and safer treatment decisions in clinical practice.
ADHD Clinical Decision Support UK: Improving Safety, Consistency, and Confidence in ADHD Care
Explore ADHD clinical decision support in the UK, including NICE-aligned assessment, prescribing, monitoring, and safer ADHD care pathways for clinicians and patients.
Methylphenidate Contraindications Checker: A Prescriber’s Guide to Safe ADHD Treatment
Use this methylphenidate contraindications checker guide to identify who should not take methylphenidate, key red flags, safety checks, and prescriber considerations.
ADHD Initiation Checklist for Prescribers: A Practical, Safe, and Evidence-Based Guide
A complete ADHD initiation checklist for prescribers. Learn safe, evidence-based steps for assessment, medication initiation, and monitoring in ADHD care.
The ADHD Prescription That Goes Wrong — Are You Covered?
Nobody goes into a consultation intending to miss something. But when a complaint is made, the question isn't whether you're a good clinician. It's whether you can demonstrate — from your records — that you did everything that should have been done. That distinction is the difference between a defensible complaint and a referral to the NMC.
ADHD Shared Care Protocol Tool: A Guide for Safer Shared Prescribing
Learn how an ADHD shared care protocol tool supports safer prescribing, monitoring, and communication between specialist and GP in adult ADHD care.
ADHD Prescribing and Medico-Legal Risk — What Your Documentation Needs to Show
The complaint arrives weeks after the consultation. By then, the prescriber is trying to reconstruct what happened from notes that say "contraindications checked — suitable to proceed." That note is not a defence. It's a conclusion without any evidence of the process that led to it. Here's what defensible ADHD prescribing documentation actually looks like.
Lisdexamfetamine Prescribing Checklist: Safe, Structured Adult ADHD Prescribing
Learn what a lisdexamfetamine prescribing checklist includes, why it matters before ADHD treatment, and how it supports safe, structured prescribing.
Pre-medication ADHD screening
Learn why pre-medication ADHD screening matters, what it includes, and how it helps determine whether ADHD medication is safe and appropriate.
The 19 QT-Prolonging Drugs Every ADHD Prescriber Needs to Know About
When we talk about drug safety in ADHD prescribing, the conversation usually starts with cardiovascular contraindications. These are the headline stops. Every prescriber knows them. What gets less attention is the patient on citalopram 40mg who wants to start atomoxetine. Or the patient on quetiapine and haloperidol where the QT risk compounds. Here are the 19 QT-prolonging drugs every ADHD prescriber needs to know — tiered by risk, with guidance on what your documentation needs to show.
ADHD Prescribing Tool UK: Safe, Structured Support for Adult ADHD Treatment
Discover how an ADHD prescribing tool UK clinicians can use supports safe, evidence-based medication decisions, titration, and monitoring for adult ADHD.
Why ADHD Pre-Medication Screening Is the Highest-Risk Step in the Private Prescribing Pathway — And What to Do About It
If you prescribe ADHD medication privately, you already know the feeling. A patient in front of you. Confirmed diagnosis. Ready to start medication. And before you can write that prescription, you need to work through a mental checklist that isn't written down anywhere in one place. Ten absolute contraindications for lisdexamfetamine alone. Thirteen for methylphenidate — several unique to that drug. QT prolongation profiles. Named MAOIs. Baseline observations. ECG indications. The risk isn't that prescribers don't know this. The risk is that without a structured, documented process — the screening and the documentation aren't consistent. And inconsistency is where medico-legal exposure begins. Here's what good pre-initiation screening actually looks like, and what I built to solve it.
ADHD Medication Screening Tool: What It Is, Who It Helps, and What Happens Next
Use an ADHD medication screening tool to check for common ADHD symptoms, understand what happens next, and decide whether a full assessment is the right step.
Inattentive ADHD: The Quiet Type Explained
Learn what inattentive ADHD is, how it differs from hyperactive ADHD, why it is often missed in women, and how to get diagnosed in the UK.
High Functioning ADHD: When No One Believes You Struggle
High functioning ADHD is real. Learn why intelligent adults mask symptoms, what hidden struggles look like, why diagnosis is missed, and how to get assessed in the UK.